Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Prevention of Maternal and Neonatal Death/Infections (A-PLUS)
NCT03871491Phase 3Completed
- Sponsor
- Global Network for Women's and Children's Health Research
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of azithromycin in maternal sepsis, neonatal sepsis, Maternal death, neonatal death, sponsored by Global Network for Women's and Children's Health Research. Started Sep 2020; status: completed.
02
Drugs
azithromycin
03
Conditions
maternal sepsisneonatal sepsisMaternal deathneonatal death
Beyond the preview
Go deeper on NCT03871491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03871491.